To view our entire molecular raw material product line for qPCR, please visit us at bioline.com

Home » About Us » News » Press Release

Press Releases
New Synthetic Cannabinoids - 1/17/2018

 

 
 
 
 
 
 
  Forward icon  
 
 
 
 
 

 

 

New Synthetic Cannabinoids

Ab and BSA Conjugate pairs for AB-PINACA and UR-144

 

 

Products

*All products are suitable for use in ELISA & LF

Y01308B MAb to A-Pinaca
• Purified, liquid
• Pairs with Y01309B
Y01309B Pinaca BSA Conjugate
• BSA, liquid
• Pairs with G01307M, G01308M or G01309M
G01308M MAb to AB-Pinaca
• Purified, liquid
• Pairs with Y01309B
G01309M MAb to AB-Pinaca
• Purified, liquid
• Pairs with Y01309B
G01307M UR-144 BSA Conjugate
• BSA, liquid
• Pairs with G01310M or G01311M
G01310M MAb to UR-144
• Purified, liquid
• Pairs with Y01308B
G01311M MAb to UR-144 Parent & Metabolite
• Purified, liquid
• Pairs with Y01308B
G01313M MAb to UR-144 Metabolite
• Purified, liquid
G01314M MAb to UR-144 Metabolite
• Purified, liquid


https://transit.createsend.com/campaigns/content/edit/0D8E7CDF702B34F4/s#

> Request more information!

Download catalog:
Drug testing reagents

 
 

 

Synthetic Cannabinoids are classed as 'New Psychoactive Substances' (NPS) which are unregulated substances that have become newly available on the market as an alternative to illegal drugs. They are a designer drug in which herbs, incense or other leafy materials are sprayed with lab-synthesized liquid chemicals to mimic the psychoactive effects of marijuana. The chemicals act on the same receptor in the human body as Δ9-tetrahydrocannabinol (THC), the main active ingredient in natural marijuana.

Compounds in designer drugs tend to change frequently in order to evade identification and scheduling by the Drug Enforcement Agency (DEA), as well as detection in drug testing laboratories. Broad-spectrum drug screening via high-resolution mass spectrometry is the best way to identify any drug compounds in emergency settings where there is intoxication or poisoning.

However in all other cases, new diagnostic assays that specifically target the new version of the drugs must be created as small variations to the chemical structure of the compounds can decrease drug testing accuracy.

Two new generations of synthetic cannabinoids are AB-PINACA and UR-144. Meridian has just released new antibodies and BSA-conjugate pairs to these targets for use in ELISA and Lateral Flow assays.

 

 

Meet us at our next conference!

Medlab Dubai
5th – 8th February 2018
Dubai, DWTC: Zaabeel 1 – 6

> Request a meeting

CACLP 2018
15th – 20th March 2018
Chongqing International Expo Center, China

> Request a meeting

 
 

 

 
back